Cargando…
Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies
Nonalcoholic fatty liver disease (NAFLD), a leading chronic disease worldwide, affects approximately a quarter of the global population. Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD and is more likely to progress to liver fibrosis than simple steatosis. NASH is also identified as...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850950/ https://www.ncbi.nlm.nih.gov/pubmed/36683713 http://dx.doi.org/10.3748/wjg.v29.i1.75 |